NanoViricides Inc. (NNVC)

[Nanotoday]

Successful testing of our drug candidates in animal models of the dermal, ocular, and genital herpesvirus diseases at the University of Wisconsin would enable us to rapidly move these drug candidates towards human clinical trials,

That's the same with my flying carpets. Successful testing would enable me to rapidly move them to market.

Operative word: would.

Bwahahahahahahaha!

This is the same old BS they've been spouting for 10+ years. More info about the size of the market and the disease than about some lab they paid to do testing, as if it's a sign of validation.

There will be no Tox completed in '18
There will be no clinicals started in '18